Rapid adoption of technologically advanced solutions in the healthcare sector is leading to the improvement of various healthcare procedures. Automated cell culture is one such procedure that aids in growing and maintaining cell lines by mechanically controlled techniques. Market Research Future (MRFR) has published a report stating that the Global Automated Cell Culture Market Share to expand at a robust CAGR of 8.5% during the forecast period of 2020-2023.
Market Drivers and Restraints:
Increasing adoption of technologically advanced solutions to carry out various procedures in the healthcare sector has improved the quality and reliability of the treatments that are provided today. Rapid automation of services and increasing emphasis of adopting automated services in order to avoid human errors are propelling the growth of the global automated cell culture market. High demand for automated services by the well-developed healthcare infrastructure in developing and developed regions are resulting in the noteworthy expansion of the global automated cell culture market. Increased research activities for the development of advanced cell culture techniques and demand or automated services in order to avoid contamination caused by manual operations are fueling the growth of the global automated cell culture market. however, lack of penetration technologically advanced healthcare solutions, absence of skilled workforce and high cost associated with the technology are likely to act as restraints on the growth of the global automated cell culture market during the forecast period.
Automated Cell Culture Market – Competitive Landscape
Tecan Trading AG (Switzerland), BD (U.S.), Sartorius (Germany), TAP Biosystems (U.K.), Cell Culture Company (U.S.), Eppendorf AG (Germany), Merck KGaA (Germany), Hamilton Company (U.S.), Thermo Fischer Scientific Inc.(U.S.), Sigma-Aldrich Corporation LLC (U.S.), Octane Biotech (Canada), EMD Millipore (U.S.), Panasonic Technologies (Japan) are some key players in Automated Cell Culture Market.
The global automated cell culture market is observed to be growing due to the increasing developments of key players like Tecan Trading AG, BD, Thermo Fischer Scientific Inc. and TAP Biosystems which fuel the market growth. The key players along with other companies dealing with automated cell culture have adopted strategies to increase their market revenue. The strategies include continuous launch of new products, acquisitions and collaborations increasing research activities to develop advanced technologies for automated cell culture.
The global automated cell culture market has been segmented on the basis of application, type, and end user. Based on the application, the automated cell culture market has been segmented into drug development, regenerative medicine, stem cell research, cancer research, and others. Based on type, the automated cell culture market has been segmented into finite cell line cultures and infinite cell line cultures. Based on consumables, the automated cell culture market has been segmented into media, sera, reagents, and others. Based on the end user, the automated cell culture market has been segmented into biotech companies, research organizations, academic institutes, and others.
Geographically, the global automated cell culture market has been segmented into four major regions such as the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas command for a significant share in the global automated cell culture market owing to the rapid adoption technologically advanced healthcare solutions for diagnosis and treatment purposes and increasing emphasis on automation of healthcare services in the well-developed healthcare infrastructure in this region. The Europe is region is projecting noteworthy expansion of the automated cell culture market owing to the increased research activities for development of innovative healthcare technologies and high adoption rate of advanced technology in this region. The automated cell culture market in the Asia Pacific region is projecting elevated growth owing to the increasing acceptance of advanced technology in the healthcare sector of developing economies in this region. The Middle East and Africa region is projecting slow growth in the global automated cell culture market owing to the low penetration of healthcare technologies in the underdeveloped areas of this region.